CTOs on the Move

SciMar

www.scimar.ca

 
SciMar is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.scimar.ca
  • 1960 2104 St Mary's Rd
    Winnipeg, MB CAN R2N 3Z4
  • Phone: 204.470.4872

Executives

Name Title Contact Details

Similar Companies

Dental Art Laboratory Inc

Dental Art Laboratory Inc is a Lansing, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Banta Healthcare Group

Banta Healthcare Group is a Neenah, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Scholars

Health Scholars is transforming clinical education and training. Our mission is to advance healthcare education through virtualization, making experience-based training scalable, accessible and affordable to both Healthcare and Public Safety providers.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

Vertebral Technologies

Vertebral Technologies, Inc. is a Minnetonka, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.